Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Cash Flows and Condensed Statement of Cash Flows (Unaudited)

v3.6.0.2
Condensed Consolidated Statement of Cash Flows and Condensed Statement of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Operating activities    
Net loss $ (10,990,894) $ (14,075,111)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 189,039 151,601
Loss on disposal of property and equipment 41,989
Stock-based compensation 2,596,280 3,030,225
Changes in operating assets and liabilities:    
(Increase) in prepaid expenses and other current assets (122,428) 313,499
(Increase) in other long-term assets (163,064) 25,751
Increase in accounts payable and accrued liabilities 73,497 1,100,097
Increase (decrease) in accrued compensation (125,994) 104,237
Increase in other long-term liabilities 305,936 292,534
Net cash used in operating activities (8,235,628) (9,015,178)
Investing activities    
Purchases of property and equipment (9,578) (1,060,910)
Net cash used in investing activities (9,578) (1,060,910)
Financing activities    
Proceeds from issuance of common stock and warrants 7,500,010
Payment of financing and offering costs (613,915)
Proceeds from exercise of warrants (Sabby) 16,808
Proceeds from issuance of common stock (ESPP) 25,615
Net cash provided by financing activities 42,423 6,886,095
Effect of exchange rate changes on cash 14
Net (decrease) in cash (8,204,769) (3,189,993)
Cash and cash equivalents, at beginning of period 28,746,224 32,035,264
Cash and cash equivalents, at end of period 20,541,455 28,845,271
Supplemental disclosure for cash flow information:    
Interest
Income taxes 1,391 2,172
Noncash investing and financing transaction:    
Fair value of placement agent warrants issued in the public offering 242,143
Issuance of common stock in connection with a contractual agreement 55,500
Noncash expiration of warrants $ 309,477